Deflazacort Completed Phase 3 Trials for Duchenne Muscular Dystrophy (DMD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01603407Finding the Optimum Regimen for Duchenne Muscular Dystrophy